Brain Pathology
Brain Pathology (Brain Pathol.) is a neuropathology journal published by Wiley on behalf of the International Society of Neuropathology and serves as the society's official title. Founded in September 1990, it concentrates on the pathological mechanisms of neurological disease, on substantial reviews and on mini-symposia, appears bimonthly, and had a 2025 impact factor of 5.0.《脑病理学》（Brain Pathology''''，缩写 Brain Pathol.''）是约翰威立代表国际神经病理学会出版的神经病理学刊物，1990 年 9 月创刊，为该学会会刊。该刊以神经系统疾病的病理机制、大型综述与专题小型研讨会为主，现为双月刊，二〇二五年影响因子为 5.0。
Scope
The journal's editorial stance is that neurological disease has to be explained through morphology and mechanism: however advanced the technique, a paper must return to the pathological change in tissue and cell and show what it means for the origin, classification or prognosis of disease. Coverage runs across the main forms of neuropathology and concentrates on:本刊的取稿立场是「以形态与机制解释神经系统疾病」：一篇论文不论技术手段多么先进，都要回到组织与细胞的病理改变上，说明它与疾病的发生、分类或预后有何关系。收文覆盖神经病理学的全部主要形态，重点包括：
- Original neuropathology research: histopathology of brain and spinal cord disease, ultrastructural observation, and the diagnostic use of immunohistochemistry and molecular pathology.神经病理学原创研究： 脑与脊髓疾病的组织病理学、超微结构观察、免疫组化与分子病理在诊断中的应用。
- Pathogenesis of neurological disease: neurodegeneration and protein aggregation, demyelination and white matter disease, cerebrovascular disease and hypoxic injury, and the pathology of epilepsy.神经系统疾病的发病机制： 神经变性与蛋白聚集、脱髓鞘与白质病变、脑血管病与缺氧损伤、癫痫相关病理。
- Brain tumour pathology: classification and grading of glial and neuronal tumours, integration of molecular typing with pathological diagnosis, meningiomas and pituitary tumours, and metastases and lymphomas.脑肿瘤病理： 胶质瘤与神经元肿瘤的分类与分级、分子分型与病理诊断的整合、脑膜瘤与垂体肿瘤、转移瘤与淋巴瘤。
- Reviews and mini-symposia: grouped reviews and focused symposia on a single neuropathological topic, a standing feature of the journal since its founding.综述与小型研讨会： 就某一神经病理学议题组织成组的综述与专题研讨，是该刊自创刊起就设置的固定栏目。
- Case images and teaching: image-led case presentations used for morphological teaching and differential diagnosis of rare or typical lesions.病例图像与教学： 以图像为主的病例展示栏目，用于罕见或典型病变的形态教学与鉴别诊断。
- Neuromuscular and peripheral nerve pathology: muscle biopsy pathology, peripheral neuropathy, motor neuron disease and disorders of the neuromuscular junction.神经肌肉与周围神经病理： 肌肉活检病理、周围神经病变、运动神经元病与神经肌肉接头疾病。
The journal became fully open access in January 2021 and has charged an article processing charge on submissions since 14 October 2020, with a ten per cent discount for members of the International Society of Neuropathology. The publisher reports an acceptance rate of 13 per cent, eleven days to first decision, 135 days to acceptance and sixteen days from acceptance to publication, the first-decision figure including editorial screening.本刊自 2021 年 1 月起转为完全开放获取，自 2020 年 10 月 14 日起对投稿收取文章处理费，国际神经病理学会会员享有九折；出版方公布录用比例为百分之十三、投稿至首次决定十一天、投稿至接收一百三十五天、接收至出版十六天，其中首次决定包含编辑部初筛。[1]
History
- Founding (1990): volume 1, issue 1 appeared in September 1990, launched by the International Society of Neuropathology in Zurich. The founder was Paul Kleihues, who described the journal as his brainchild创刊（1990年）： 1990 年 9 月出版第 1 卷第 1 期，由国际神经病理学会在苏黎世创办，创刊人为（Paul Kleihues），他把本刊称为自己的构想与心血；创刊动因是为大型综述与小型研讨会提供专门园地。 the rationale was to provide a dedicated venue for substantial reviews and mini-symposia.[2]
- Publisher: the society published the journal itself at first, resolved in 2005 to move to commercial publication with Blackwell, completed the transfer around 2006, and the title subsequently became a Wiley-Blackwell journal with the absorption of Blackwell into Wiley.出版方沿革： 创刊初期由学会自行出版，2005 年学会决议转由（Blackwell）商业出版，2006 年前后完成交接，其后随（Blackwell）并入约翰威立体系，成为（Wiley-Blackwell）刊物。[3]
- Open access transition (2021): the journal became fully open access in January 2021, with all research content free to read on publication. The society retained its member discount and the journal is now listed in DOAJ.开放获取转型（2021年）： 2021 年 1 月起本刊转为完全开放获取，所有研究内容一经发表即可自由阅读；学会同时保留会员折扣，本刊现被 DOAJ 收录。[4]
- Frequency and metrics: the journal moved from quarterly at founding to bimonthly, six issues a year. For 2025 the impact factor is 5.0, the CiteScore 10.9 and the journal citation indicator 1.45, and it is indexed in DOAJ, Scopus, MEDLINE and the Science Citation Index Expanded. The publisher's page also carries 2024 figures of 11.2 for CiteScore and 6.2 for impact factor alongside the current ones.刊期与指标： 本刊由创刊时的季刊改为双月刊，每年六期；二〇二五年影响因子 5.0、引用分数 10.9、期刊引文指标 1.45，被 DOAJ、Scopus、MEDLINE 与科学引文索引扩展版收录；出版方页面上另有 2024 年口径的引用分数 11.2 与影响因子 6.2，与现值并存。[1]
Editors
The journal has a complete official record of editorial succession, unusually clear among neuropathology titles. The present editor is based in the United States and her predecessors all came from university hospital pathology departments in Europe or the United States, with tenures of five to eight years.本刊的主编更替有完整的官方任期记录，是神经病理学刊物中沿革较为清楚的一种；现任主编来自美国，前任均来自欧洲或美国的大学医院病理科，任期为五年至八年不等。[5]
- Present editor-in-chief: M. Beatriz S. Lopes of the University of Virginia works on pituitary and brain tumour pathology. The site does not state the year of appointment现任主编： （M. Beatriz S. Lopes）供职于弗吉尼亚大学，研究方向为垂体与脑肿瘤病理；官网未标注就任年份，据前任任期推定为 2025 年起。 on the basis of her predecessor's term it is taken to be 2025.
- Past editors: Paul Kleihues was the founding editor, serving from 1990 to 1995 at the University of Zurich. He was followed by Clayton A. Wiley from 1996 to 2000, Harry V. Vinters from 2001 to 2006, Arie Perry from 2007 to 2014, Seth Love from 2014 to 2018 and Markus Glatzel from 2018 to 2025.历任主编： （Paul Kleihues）任首任主编，1990 年至 1995 年在任，供职于苏黎世大学；其后依次为（Clayton A. Wiley）1996 年至 2000 年、（Harry V. Vinters）2001 年至 2006 年、（Arie Perry）2007 年至 2014 年、（Seth Love）2014 年至 2018 年、（Markus Glatzel）2018 年至 2025 年。[5]
- Role in the field: as the official journal of the International Society of Neuropathology, its mini-symposia have long been used to develop society-level consensus on morphology and classification for a given disease, and it regularly hosts discussion of diagnostic criteria.学科角色： 本刊是国际神经病理学会的会刊，其小型研讨会栏目长期用于就某一疾病形成学会层面的形态学与分类共识，也常成为诊断标准讨论的发表园地。